Healthcare provider profile · identity verified

Yamil Mateo, MD

General Practice · SALINAS, PR · NPI 1063555498

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Simvastatin	Simvastatin	855	148
Synthroid	Levothyroxine Sodium	570	92
Atorvastatin Calcium	Atorvastatin Calcium	481	75
Omeprazole	Omeprazole	397	62
Losartan Potassium	Losartan Potassium	299	51
Gabapentin	Gabapentin	286	48
Glipizide	Glipizide	267	34
Amlodipine Besylate	Amlodipine Besylate	264	42
Metformin Hcl	Metformin Hcl	258	45
Metoprolol Tartrate	Metoprolol Tartrate	258	46
Clonazepam	Clonazepam	222	28
Hydrochlorothiazide	Hydrochlorothiazide	201	38
Famotidine	Famotidine	196	33
Lisinopril	Lisinopril	185	29
Pantoprazole Sodium	Pantoprazole Sodium	181	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	169	23
Tamsulosin Hcl	Tamsulosin Hcl	168	24
Allopurinol	Allopurinol	163	27
Alprazolam	Alprazolam	143	21
Atenolol	Atenolol	142	32
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	141	67
Montelukast Sodium	Montelukast Sodium	138	43
Metoprolol Succinate	Metoprolol Succinate	137	22
Alendronate Sodium	Alendronate Sodium	136	23
Furosemide	Furosemide	114	24
Fenofibrate	Fenofibrate	113	19
Tramadol Hcl	Tramadol Hcl	111	21
Meloxicam	Meloxicam	109	34
Levothyroxine Sodium	Levothyroxine Sodium	104	17
Humulin N	Insulin Nph Human Isophane	101	14
Fenofibrate	Fenofibrate Nanocrystallized	100	14
Carvedilol	Carvedilol	99	17
Clopidogrel	Clopidogrel Bisulfate	98	14
Glimepiride	Glimepiride	87	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	84	15
Insulin Syringe	Syringe And Needle,insulin,1ml	78	15
Meclizine Hcl	Meclizine Hcl	69	28
Fluticasone Propionate	Fluticasone Propionate	66	23
Hydralazine Hcl	Hydralazine Hcl	59	suppressed
Nifedipine Er	Nifedipine	59	11
Lorazepam	Lorazepam	54	11
Duloxetine Hcl	Duloxetine Hcl	53	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	52	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	51	suppressed
Finasteride	Finasteride	50	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	49	suppressed
Irbesartan	Irbesartan	49	suppressed
Naproxen	Naproxen	49	11
Rosuvastatin Calcium	Rosuvastatin Calcium	48	suppressed
Sertraline Hcl	Sertraline Hcl	45	suppressed
Temazepam	Temazepam	45	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	44	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	44	31
Indapamide	Indapamide	42	suppressed
Spironolactone	Spironolactone	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Cilostazol	Cilostazol	40	suppressed
Ezetimibe	Ezetimibe	39	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	39	suppressed
Nabumetone	Nabumetone	39	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Verapamil Er	Verapamil Hcl	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	30
Fenofibric Acid	Fenofibric Acid (Choline)	36	suppressed
Azithromycin	Azithromycin	35	22
Latanoprost	Latanoprost	34	suppressed
Sulindac	Sulindac	31	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Pregabalin	Pregabalin	30	suppressed
Clindamycin Hcl	Clindamycin Hcl	29	19
Diclofenac Sodium	Diclofenac Sodium	29	14
Donepezil Hcl	Donepezil Hcl	27	suppressed
Farxiga	Dapagliflozin Propanediol	27	suppressed
Methylprednisolone	Methylprednisolone	27	21
Clonidine Hcl	Clonidine Hcl	26	suppressed
Prednisone	Prednisone	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Baclofen	Baclofen	23	suppressed
Enalapril Maleate	Enalapril Maleate	22	suppressed
Fosinopril Sodium	Fosinopril Sodium	22	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	22	suppressed
Pentoxifylline	Pentoxifylline	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Eliquis	Apixaban	21	suppressed
Etodolac	Etodolac	21	suppressed
Calcitriol	Calcitriol	20	suppressed
Etodolac Er	Etodolac	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	19	suppressed
Valsartan	Valsartan	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Warfarin Sodium	Warfarin Sodium	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Betamethasone Valerate	Betamethasone Valerate	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Digoxin	Digoxin	17	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	17	14
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Mupirocin	Mupirocin	16	14
Orphenadrine Citrate	Orphenadrine Citrate	16	12
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	14	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	14	13
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Brilinta	Ticagrelor	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Colchicine	Colchicine	13	suppressed
Crestor	Rosuvastatin Calcium	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Linzess	Linaclotide	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Diclofenac Potassium	Diclofenac Potassium	12	suppressed
Glyxambi	Empagliflozin/Linagliptin	12	suppressed
Ramipril	Ramipril	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Estazolam	Estazolam	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Methimazole	Methimazole	11	suppressed
Pen Needle	Pen Needle, Diabetic	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error